Biotechnology Business
Abiomed Announces Update on European Growth Strategy
Published in Hospital Business Week, January 13th, 2008
There are over 200,000 deaths annually in Germany, France, UK, Spain, Italy and Russia from acute myocardial infarction (AMI).(1) Abiomed's portfolio of circulatory care products including Impella(R), iPulse(TM) and AB5000(R) are approved in 27 European Union (EU) countries through CE-Mark approval, and Impella is now approved in over 40 countries outside the United States. Abiomed announced that it has continued to invest in its sales, clinical, marketing and field service teams in Europe, now...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- 012 Smile.Communications Ltd
012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center - AdvancedMD Software Inc.
AdvancedMD's Practice Management Solution Named 'BEST IN KLAS' for 2007 - Agency for Healthcare Research & Quality
Blacks, Hispanics and Other Groups Less Likely to Get Strong Pain Medications in Hospital Emergency Departments - Breast Cancer
Breast Cancer Gene Mutation More Common in Hispanic, Young Black Women, Stanford/NCCC Study Finds - Cancer
Murray Leads Delegation in Securing $2.1 Million for Proton Therapy Center - Cancer
Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
